NCT06443593View on ClinicalTrials.gov

Effect of Micronutrient Supplementation on Nerve Conduction Velocity in T1D- RCT

NARecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

February 8, 2024

Primary Completion Date

February 8, 2025

Study Completion Date

February 8, 2025

Conditions
Type 1 Diabetes
Interventions
DIETARY_SUPPLEMENT

Tablet VitaBliss vitamin B12 (2.2 mcg)

Oral vitamin B12 supplement 2.2 mcg from BLISS WELNESS, Bliss Lifesciences, LLP to be administered once daily for 24 weeks

DIETARY_SUPPLEMENT

Tablet VitaBliss vitamin B12 (2.2 mcg) and Syrup Orofer (5 ml = 50 mg)

Oral vitamin B12 supplement 2.2 mcg from BLISS WELNESS, Bliss Lifesciences, LLP to be administered once daily for 24 weeks and oral iron 25 mg from Emcure Pharmaceuticals Ltd. to be administered once daily for 24 weeks

DIETARY_SUPPLEMENT

Tablet VitaBliss vitamin B12 (2.2 mcg) and Tablet Tayo (60000 IU)

Oral vitamin B12 supplement 2.2 mcg from BLISS WELNESS, Bliss Lifesciences, LLP to be administered once daily for 24 weeks and oral vitamin D3 (60000 IU) from Eris Lifesciences Ltd to be administered once in 3 months for 24 weeks

Trial Locations (1)

411001

RECRUITING

Hirabai Cowasji Jehangir Medical Research Institute, Pune

All Listed Sponsors
lead

Hirabai Cowasji Jehangir Medical Research Institute

OTHER